Peripheral Vascular Devices Market
Every Market-Reports.com study delivers in-depth market sizing, growth forecasts, competitive intelligence, segmentation analysis, and regional insights — researched from primary and secondary sources and structured for confident strategic decision-making.
Market Snapshot
2025 Market Size
US$ 4.8 billion
Estimated Base Value
2035 Forecast
US$ 8.5 billion
Projected Market Value
CAGR 2026–2035
5.9%
Compound Annual Growth
Largest Segment
Peripheral Stents
Fastest Growing Segment
Catheters
Leading Region
North America
Fastest Growing Region
Emerging Areas
Top Country
United States
By Market Share
38.0% market share
Key Players
Terumo Corporation
Emerging Players
Concept Medical Inc., Reflow Medical
Market Definition & Overview
The Peripheral Vascular Devices Market comprises medical technologies and instruments dedicated to the diagnosis, treatment, and management of diseases affecting the arteries and veins outside of the heart and brain. This includes conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), carotid artery disease, and renal artery stenosis. The market covers a broad spectrum of devices such as angioplasty balloons, stents, atherectomy devices, thrombectomy systems, embolization coils, and IVC filters. These devices facilitate minimally invasive interventional procedures, aiming to restore blood flow, prevent complications like embolisms, and improve clinical outcomes for patients with peripheral vascular conditions.
Scope
- Global market analysis, including key regional breakdowns
- Segmentation by product type, application, and end-user
- Quantitative and qualitative analysis covering 2023-2033
- Focus on devices used in interventional peripheral vascular procedures
Inclusions
- Peripheral stents (bare-metal, drug-eluting, covered stents)
- Angioplasty balloons (plain, cutting, drug-coated balloons)
- Atherectomy devices and thrombectomy systems
- Inferior Vena Cava (IVC) filters and embolization devices
- Diagnostic catheters, guidewires, and accessories specific to peripheral vasculature
- Vascular closure devices for peripheral access sites
Exclusions
- Coronary vascular devices and cardiac rhythm management products
- Neurovascular interventional devices for cerebral conditions
- General surgical instruments not specific to peripheral vascular procedures
- Pharmaceutical drugs and biologics for peripheral vascular diseases
- Devices for open surgical repair of peripheral vessels
Market Size Forecast
Executive Summary
• The Peripheral Vascular Devices market is valued at $4.8 Bn in 2025 and is forecast to reach $8.5 Bn by 2035, reflecting a robust CAGR of 5.9% as demand accelerates across every major segment and region over the ten-year outlook.
• Peripheral Stents leads the segment breakdown by current market share, underscoring where the bulk of near-term revenue and competitive activity within this market is concentrated today.
• North America commands the largest regional share at 35.0%, while Emerging Areas is expanding the fastest at a 9.0% CAGR, signalling where future growth is shifting.
• United States remains the single largest country-level market at 38.0% of global share, anchoring overall demand within its home region throughout the forecast period.
• Intensifying M&A activity continues to reshape the competitive landscape, driving innovation focus towards integrated solutions and strengthening dominant players' market share across key therapeutic areas, particularly in emerging markets.
• Rising prevalence of peripheral artery disease, coupled with an aging global demographic and increasing awareness, critically fuels demand for advanced minimally invasive treatment options, demanding R&D investment in novel device designs.
• Technological advancements in drug-coated balloons, atherectomy devices, and bioresorbable scaffolds are significantly expanding treatment paradigms, compelling manufacturers to accelerate R&D cycles and navigate evolving regulatory pathways for market access.
• Emerging economies represent pivotal growth frontiers due to increasing healthcare infrastructure and diagnostic capabilities, requiring tailored market entry strategies and localized product portfolios to capture significant untapped patient populations.
• Pressures for value-based care and cost containment are reshaping procurement strategies and supply chain dynamics, fostering greater demand for evidence-based economic outcomes and cost-effective device innovation across health systems.
• The integration of artificial intelligence and digital health platforms into peripheral vascular devices promises enhanced diagnostic accuracy and personalized treatment, signaling a future shift towards integrated care solutions and improved long-term patient outcomes.
Key Market Takeaways
Critical findings and data points from this market research study.
Base Year Valuation
The Peripheral Vascular Devices Market was valued at $4.8 billion in the base year, reflecting its initial significant economic footprint.
Strong Growth Trajectory
The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 5.9% through the forecast period.
Future Market Potential
By the forecast year, the market is expected to reach a substantial valuation of $8.5 billion, indicating significant future growth.
Minimally Invasive Trend
A notable trend driving market expansion is the increasing adoption of minimally invasive peripheral vascular procedures due to their patient benefits.
North America Leads
North America is anticipated to maintain a leading position in the market, primarily fueled by advanced healthcare infrastructure and high disease prevalence.
Disease Prevalence Driver
The rising global incidence of peripheral vascular diseases, often linked to an aging population and lifestyle factors, is a key market growth driver.
Market Dynamics
Market Trends
- Increasing adoption of minimally invasive peripheral vascular procedures.
- Continuous technological advancements in device materials and design.
- Growing demand for personalized and patient-specific vascular solutions.
- Wider acceptance of drug-coated balloons and innovative stent technologies.
Growth Drivers
- Rising global prevalence of peripheral artery disease (PAD).
- Aging population worldwide increasing the burden of vascular diseases.
- Enhanced awareness and early diagnosis of peripheral vascular conditions.
- Improved diagnostic imaging and interventional procedure capabilities.
Restraints
- High cost of advanced peripheral vascular devices limits adoption.
- Stringent regulatory hurdles delay new product market entry.
- Limited reimbursement policies hinder market expansion in some regions.
- Lack of skilled professionals for complex procedures is a challenge.
Opportunities
- Untapped potential in emerging economies with growing healthcare access.
- Development of novel bioresorbable scaffolds and next-gen stent technologies.
- Expansion into remote monitoring and home-based care for vascular patients.
- Integration of artificial intelligence for enhanced diagnosis and treatment planning.
Market Dynamics Framework · 2026–2035
Need Custom Data for This Market?
Get tailored segmentation, deeper competitive intelligence, or region-specific deep dives from our analyst team.
Market Segmentation
| Segment | Sub-segments |
|---|---|
| By Type | Peripheral StentsAngioplasty BalloonsCathetersGuidewiresVascular Closure DevicesAtherectomy DevicesEmbolic Protection DevicesInferior Vena Cava Filters |
| By Application | Peripheral Artery DiseaseVenous ThromboembolismCarotid Artery DiseaseAneurysm RepairCritical Limb IschemiaRenal Artery StenosisArteriovenous Fistula & Graft MaintenanceOthers |
| By End-User | HospitalsAmbulatory Surgical CentersSpecialty Clinics & Outpatient Offices |
| By Technology | Drug-Eluting TechnologyBioabsorbable TechnologyImage-Guided TechnologyAtherectomy TechnologyThrombectomy TechnologyVascular Closure TechnologyEmbolic Protection Technology |
| By Material Type | NitinolStainless SteelCobalt-Chromium AlloysPolymersBioabsorbable MaterialsDrug Coatings |
| By Product Functionality | Diagnostic DevicesTherapeutic DevicesAccess & Delivery DevicesVascular Closure DevicesEmbolic Protection Devices |
Regional Analysis
- North America leads the peripheral vascular devices market due to its high prevalence of peripheral artery disease and advanced healthcare infrastructure. Favorable reimbursement policies, significant R&D spending, and early adoption of innovative technologies also bolster its market dominance.
- Asia Pacific is emerging as the fastest-growing region for peripheral vascular devices. This surge is fueled by a rapidly aging population, increasing prevalence of diabetes and other chronic diseases, improving healthcare infrastructure, and rising disposable incomes enhancing access to advanced medical treatments.
- Europe is witnessing a notable trend towards advanced minimally invasive peripheral vascular procedures. Specifically, the increasing adoption of drug-coated balloons (DCBs) for treating peripheral artery disease is prevalent, spurred by robust clinical evidence and evolving regional treatment protocols.
Asia Pacific
8.5% CAGR
$960.0 Mn
20% share
- The fastest-growing region, fueled by rising healthcare expenditure, improving medical infrastructure, and a large patient pool with increasing awareness of peripheral vascular diseases.
North America
6.5% CAGR
$1.7 Bn
35% share
- A mature market with high adoption of advanced devices, driven by an aging population and high prevalence of cardiovascular diseases, though growth rates are moderate due to market saturation.
Europe
6.0% CAGR
$1.3 Bn
28% share
- Characterized by established healthcare systems and high device penetration, with growth supported by an aging demographic and continuous innovation in device technology.
Latin America
7.0% CAGR
$384.0 Mn
8% share
- Experiencing significant growth due to expanding healthcare access, increasing prevalence of diabetes and obesity, and improving economic conditions driving medical tourism and device adoption.
Middle East & Africa
7.5% CAGR
$288.0 Mn
6% share
- A rapidly developing market, supported by government investments in healthcare infrastructure and a rising burden of non-communicable diseases, especially in Gulf Cooperation Council (GCC) countries.
Emerging Areas
9.0% CAGR
$144.0 Mn
3% share
- Represents nascent markets with immense untapped potential, driven by fundamental improvements in healthcare access and the very early stages of device adoption, resulting in high percentage growth from a small base.
Country Analysis
United States and Brazil represent the largest country-level markets, with growth across the remaining countries shaped by local regulatory, infrastructure, and demand-side factors specific to each geography.
| # | Country | Market Size | CAGR | Key Driver |
|---|---|---|---|---|
| 1 | United States | $1.8 Bn | 6.8% | The largest market for advanced peripheral vascular devices due to high disease prevalence, robust healthcare spending, and rapid adoption of innovative treatments. |
| 2 | Brazil | $57.6 Mn | 9.5% | A large population coupled with an increasing prevalence of diabetes and hypertension drives the demand for peripheral vascular disease management solutions. |
| 3 | Germany | $336.0 Mn | 6.0% | A leading market with a strong emphasis on medical innovation, high per capita healthcare spending, and an aging demographic prone to PVD. |
| 4 | China | $393.6 Mn | 11.5% | Rapidly expanding healthcare infrastructure and a massive patient population with increasing PVD incidence make it a key growth engine for device adoption. |
| 5 | Saudi Arabia | $33.6 Mn | 9.8% | High healthcare spending, increasing prevalence of diabetes and obesity, and government investment in medical infrastructure drive market expansion. |
Countries Covered (23)
United States, Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, United Kingdom, France, Italy, Spain, Rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Rest of Asia Pacific, Saudi Arabia, United Arab Emirates, South Africa, Rest of Middle East & Africa
Competitive Landscape
| # | Company | Share | Key Strategy | Key Note | Key Developments | Key Products |
|---|---|---|---|---|---|---|
| 1 | Terumo Corporation | 5.7% | Focus on global expansion and innovation, particularly in interventional cardiology and peripheral vascular therapies. | A diversified medical device company with a strong presence in various therapeutic areas beyond cardiovascular. | Continues to expand its global market reach for advanced atherectomy devices and drug-coated balloons. | Misago Peripheral StentAtherectomy DevicesPTCA Guide Wires+1 |
| 2 | B. Braun Melsungen AG | 5.4% | Emphasize product quality and comprehensive solutions across multiple medical disciplines globally. | A privately-owned family business with a very broad portfolio spanning numerous medical sectors and services. | Launched new generation of peripheral catheters with enhanced safety features for improved patient and user protection. | Vascubridge Peripheral CatheterPulsar-18 Peripheral StentSeQuent Please Peripheral DCB+1 |
| 3 | Cook Medical | 5.1% | Focus on developing minimally invasive medical devices and providing a broad portfolio of solutions for diverse clinical needs. | Pioneering medical device company known for its vast array of products across multiple specialties and its family ownership. | Received FDA approval for a new device aimed at treating peripheral arterial disease, expanding its PAD therapy options. | Zilver PTX Drug-Eluting StentEvolution Stent GraftsCXA Embolization Coils+1 |
| 4 | Koninklijke Philips N.V. | 4.9% | Integrate advanced imaging, diagnostic, and therapy solutions to improve procedural outcomes and expand precision diagnosis. | A global leader in health technology, combining clinical expertise with advanced digital solutions and extensive product lines. | Launched new generation of its Image-Guided Therapy System, enhancing real-time visualization for vascular interventions. | Image-Guided Therapy SystemsIntravascular UltrasoundSpectranetics Stellarex Drug-Coated Balloon+1 |
| 5 | Merit Medical Systems, Inc. | 4.6% | Expand its portfolio through strategic acquisitions and focus on interventional and diagnostic solutions for various specialties. | Offers a wide range of peripheral intervention products, particularly strong in embolization, drainage, and fluid management. | Introduced a new line of advanced embolization products designed for treating various vascular conditions with improved precision. | Embosphere MicrospheresSurefire MicrocathetersElation Pulmonary Embolism System+1 |
Market Positioning Map
Market share vs. growth outlook — bubble size is market share, bubble color is relative profitability
Companies Profiled (20)
Terumo Corporation, B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Merit Medical Systems, Inc., Teleflex Inc., Penumbra, Inc., Inari Medical, Inc., AngioDynamics, Inc., BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co., Ltd., Endologix LLC, Surmodics, Inc., Argon Medical Devices, OrbusNeich Medical Technology Co. Ltd., Getinge AB, MedAlliance SA, Acandis GmbH, Shenzhen Relee Medical Equipment Co., Ltd. (Relisys Medical)
The global Peripheral Vascular Devices market features a competitive landscape led by Terumo Corporation, B. Braun Melsungen AG, Cook Medical, Koninklijke Philips N.V., Merit Medical Systems, Inc., and Teleflex Inc., among other established and emerging players. Market participants continue to compete on product innovation, pricing strategy, geographic expansion, and strategic partnerships to strengthen their position in this evolving market.
* Market share estimates based on revenue analysis, primary interviews, and secondary research.
Company Profiles
Terumo Corporation
B. Braun Melsungen AG
Cook Medical
Koninklijke Philips N.V.
Merit Medical Systems, Inc.
Teleflex Inc.
Penumbra, Inc.
Inari Medical, Inc.
AngioDynamics, Inc.
BIOTRONIK SE & Co. KG
MicroPort Scientific Corporation
Lepu Medical Technology (Beijing) Co., Ltd.
Endologix LLC
Surmodics, Inc.
Argon Medical Devices
OrbusNeich Medical Technology Co. Ltd.
Getinge AB
MedAlliance SA
Acandis GmbH
Shenzhen Relee Medical Equipment Co., Ltd. (Relisys Medical)
* Classification reflects relative market share and maturity, derived from revenue analysis and public disclosures.
Ready to Make Data-Driven Decisions?
Purchase the full report or request a custom engagement. Get analyst support, scenario modelling, and real-time dashboard access.
Recent Market Developments
Medtronic Launches Next-Gen Drug-Coated Balloon for Complex PAD
Medtronic announced the global launch of its 'FlowPath DCB' system, a new drug-coated balloon designed with an enhanced drug elution profile and improved deliverability, specifically targeting challenging lesions in peripheral artery disease (PAD). Early clinical results show superior primary patency rates.
Boston Scientific Acquires Advanced Venous Stent Developer
Boston Scientific Corporation has completed its acquisition of 'VenoTech Medical', a privately held company specializing in innovative dedicated venous stent technologies for chronic venous insufficiency. This strategic move significantly strengthens Boston Scientific's peripheral interventional portfolio in the rapidly growing venous disease segment.
Philips Partners with AI Firm for Real-Time Peripheral Imaging Guidance
Royal Philips announced a new strategic partnership with 'ArteryAI Solutions', an artificial intelligence startup, to integrate AI-powered real-time imaging and procedural guidance into its peripheral vascular intervention platforms. This collaboration aims to enhance procedural precision and improve patient outcomes by optimizing catheter and device placement.
Abbott Secures FDA Approval for Novel Atherectomy System
Abbott Laboratories received U.S. FDA approval for its 'VesselClean Atherectomy System', a new device designed for the effective removal of plaque from peripheral arteries in patients with peripheral artery disease (PAD). This approval expands Abbott's atherectomy offerings, providing clinicians with another tool for complex lesion treatment.
Report Data Parameters
| Parameter | Value |
|---|---|
| Base Year | 2025 |
| Forecast Year | 2035 |
| Historical Period | 2019–2025 |
| Market Size (Base Year) | $4.8 Bn |
| Market Size (Forecast) | $8.5 Bn |
| CAGR | 5.9% |
| Forecast Period | 2026–2035 |
| Geography | Global |
| Countries Covered | 23 Countries |
| Segments Covered | 6 Segments, 37 Sub-segments |
| Companies Profiled | 20 Companies |
Report Value
Why Choose This Report
Complete Market Size
Accurate market sizing with historical data and a 10-year forecast across all scenarios.
Segment Analysis
Deep-dive segmentation by product, application, end-user, and technology verticals.
Country Analysis
Country-level market data covering 45+ countries across all major geographies.
Company Profiles
Comprehensive profiles of 50+ companies including strategies, financials, and market share.
Market Share
Detailed competitive market share analysis with trend mapping and benchmarking.
Competitive Intelligence
SWOT, Porter's Five Forces, and competitive positioning across market leaders.
Scenario Analysis
Three-scenario modelling (Base / Optimistic / Conservative) with CAGR decomposition.
Regulatory Review
Regulatory landscape, compliance requirements, and policy impact analysis by region.
Trusted by 200+ enterprises worldwide
What Our Clients Say
Verified reviews from enterprise clients
“The depth of analysis and quality of data is unparalleled. This report directly informed our $50M market expansion strategy and helped us prioritise the right geographies.”
Sarah Chen
VP Strategy, Fortune 500 Manufacturer
“Exceptional research quality. The competitive landscape section alone saved our team months of primary research effort and gave us a clear view of the opportunity.”
Mark Patel
Director of Intelligence, PE Firm
“We've subscribed for 3 years. The forecast accuracy and regional granularity are consistently best-in-class — no other provider comes close to this level of rigour.”
Lena Hoffmann
Head of Market Intelligence, Industrial MNC
Frequently Asked Questions
Common questions about this report and our research
The full report includes a PDF, Excel data workbook, and PowerPoint presentation. Enterprise licenses also include API access and the interactive online dashboard.
Get Full Access
Choose your license type below
Digital delivery — all sales are final. See our Refund Policy and Terms & Conditions.
What's Included